Cell line · CVCL_8607
Papers41
21 to 40 of 41
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| IGF1R Inhibition Enhances the Therapeutic Effects of Gq/11 Inhibition in Metastatic Uveal Melanoma Progression. | Mol Cancer Ther | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Targeting IRS-1/2 in Uveal Melanoma Inhibits In Vitro Cell Growth, Survival and Migration, and In Vivo Tumor Growth. | Cancers (Basel) | 2022 | Its Methods give the RRID and name the line | PubMed | |
| Quantitative proteomic dataset of whole protein in three melanoma samples of 92.1, 92.1-A and 92.1-B. | Data Brief | 2022 | Cellosaurus cites it | PubMed | |
| Oncogenic Gq/11 signaling acutely drives and chronically sustains metabolic reprogramming in uveal melanoma. | J Biol Chem | 2022 | Its Methods give the RRID and name the line | PubMed | |
| Dual Inhibition of Histone Deacetylases and the Mechanistic Target of Rapamycin Promotes Apoptosis in Cell Line Models of Uveal Melanoma. | Invest Ophthalmol Vis Sci | 2021 | Its Methods give the RRID and name the line | PubMed | |
| Targeting primary and metastatic uveal melanoma with a G protein inhibitor. | J Biol Chem | 2021 | Its Methods give the RRID and name the line | PubMed | |
| Uveal melanoma cells use ameboid and mesenchymal mechanisms of cell motility crossing the endothelium. | Mol Biol Cell | 2021 | Its Methods give the RRID and name the line | PubMed | |
| Metabolic Adaptations to MEK and CDK4/6 Cotargeting in Uveal Melanoma. | Mol Cancer Ther | 2020 | Cellosaurus cites it | PubMed | |
| Elevated Endogenous SDHA Drives Pathological Metabolism in Highly Metastatic Uveal Melanoma. | Invest Ophthalmol Vis Sci | 2019 | Its Methods give the RRID and name the line | PubMed | |
| Targeting the Senescence-Overriding Cooperative Activity of Structurally Unrelated H3K9 Demethylases in Melanoma. | Cancer Cell | 2018 | Its Methods give the RRID and name the line | PubMed | |
| Uveal Melanoma Cell Lines: Where do they come from? (An American Ophthalmological Society Thesis). | Trans Am Ophthalmol Soc | 2016 | Cellosaurus cites it | PubMed | |
| Establishment of novel cell lines recapitulating the genetic landscape of uveal melanoma and preclinical validation of mTOR as a therapeutic target. | Mol Oncol | 2014 | Cellosaurus cites it | PubMed | |
| Mutual exclusivity analysis of genetic and epigenetic drivers in melanoma identifies a link between p14 ARF and RARβ signaling. | Mol Cancer Res | 2013 | Cellosaurus cites it | PubMed | |
Evidence of epidermal growth factor receptor expression in uveal melanoma: inhibition of epidermal growth factor-mediated signalling by Gefitinib and Cetuximab triggered antibody-dependent cellular cytotoxicity. | Eur J Cancer | 2013 | Cellosaurus cites it | PubMed | |
| A high-throughput panel for identifying clinically relevant mutation profiles in melanoma. | Mol Cancer Ther | 2012 | Cellosaurus cites it | PubMed | |
| Genetic and molecular characterization of uveal melanoma cell lines. | Pigment Cell Melanoma Res | 2012 | Cellosaurus cites it | PubMed | |
| HLA and melanoma: multiple alterations in HLA class I and II expression in human melanoma cell lines from ESTDAB cell bank. | Cancer Immunol Immunother | 2009 | Cellosaurus cites it | PubMed | |
| Transcriptional profiling of human uveal melanoma from cell lines to intraocular tumors to metastasis. | Clin Exp Metastasis | 2007 | Cellosaurus cites it | PubMed | |
| Molecular cytogenetic evaluation of 10 uveal melanoma cell lines. | Cancer Genet Cytogenet | 2006 | Cellosaurus cites it | PubMed | |
| Efficacy of five human melanocytic cell lines in experimental rabbit choroidal melanoma. | Melanoma Res | 2005 | Cellosaurus cites it | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_8607/papers?page=2